Zhou X, Chen Y, Cui L, Shi Y, Guo C
Selenoprotein P, the main selenium transport protein in plasma (133), delivers selenium to the brain via receptor-mediated transcytosis across the bloodbrain barrier (134)
It sits in a group of treatments known as skin boosters, which a research review describes as a wide array of ingredients employed to enhance and improve skin condition when placed into the skin, marking a shift away from using injectables purely to plump one area, as noted in this skin booster classification paper
Its important to remember that weeks 1-8 of treatment are a titration period
Patient results vary and typically depend more on dose adherence, lifestyle changes, and ongoing medical supervision than on brand-name vs compounded status
The US pharma giant, riding high on the skyrocketing sales of its dual agonist tirzepatide, is betting on the new molecules novel design of simultaneously targeting three distinct metabolic receptors, GLP-1, GIP, and Glucagon